Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)
CUSIP: 08205P209
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001
- Shares outstanding
- 35,393,481
- Total 13F shares
- 22,685,530
- Share change
- +1,440,314
- Total reported value
- $265,306,276
- Price per share
- $11.70
- Number of holders
- 56
- Value change
- +$16,737,178
- Number of buys
- 37
- Number of sells
- 16
Quarterly Holders Quick Answers
What is CUSIP 08205P209?
CUSIP 08205P209 identifies BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 08205P209:
Top shareholders of BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
28%
|
9,876,506
|
$128,493,343 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
8.2%
|
2,918,950
|
$38,997,172 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
8.1%
|
2,860,726
|
$37,218,045 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
5.6%
|
1,972,524
|
$25,662,537 | — | 31 Mar 2025 | |
| INFINITUM ASSET MANAGEMENT, LLC |
13F
|
Company |
3.2%
|
1,125,000
|
$18,913,250 | — | 31 Mar 2025 | |
| HBM Healthcare Investments (Cayman) Ltd. |
13D/G
|
— |
4.5%
|
1,041,669
|
$14,156,282 | $0 | 31 Dec 2024 | |
| Nantahala Capital Management, LLC |
13D/G
13F
|
Company |
4.4%
|
1,038,371
|
$14,111,462 | $0 | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.92%
|
327,034
|
$4,254,713 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.74%
|
261,764
|
$3,405,548 | — | 31 Mar 2025 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
250,000
|
$3,252,500 | — | 31 Mar 2025 | |
| Steven Michael Oliveira |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,000,000
|
$3,044,300 | — | 28 Apr 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.66%
|
233,820
|
$3,043,163 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.64%
|
226,096
|
$2,941,509 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.52%
|
184,426
|
$2,399,382 | — | 31 Mar 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.39%
|
137,977
|
$1,795,081 | — | 31 Mar 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.24%
|
83,198
|
$1,082,000 | — | 31 Mar 2025 | |
| Longaeva Partners L.P. |
13F
|
Company |
0.23%
|
80,000
|
$1,040,800 | — | 31 Mar 2025 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.22%
|
76,735
|
$998,322 | — | 31 Mar 2025 | |
| Lion Point Capital, LP |
13F
|
Company |
0.18%
|
62,000
|
$806,620 | — | 31 Mar 2025 | |
| MYDA Advisors LLC |
13F
|
Company |
0.15%
|
52,000
|
$676,520 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.13%
|
45,883
|
$596,938 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
45,877
|
$596,860 | — | 31 Mar 2025 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.11%
|
39,330
|
$511,683 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.1%
|
34,418
|
$447,778 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
32,046
|
$416,918 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
26,660
|
$346,847 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.07%
|
25,927
|
$337,000 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
21,190
|
$275,682 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.05%
|
19,003
|
$247,229 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
10,012
|
$130,256 | — | 31 Mar 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.02%
|
8,458
|
$110,000 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
6,155
|
$80,077 | — | 31 Mar 2025 | |
| GAMMA Investing LLC |
13F
|
Company |
0.02%
|
5,965
|
$77,605 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.01%
|
2,816
|
$36,636 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.01%
|
1,817
|
$23,000 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
292
|
$3,799 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
208
|
$3,000 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
186
|
$2,419 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
89
|
$1,158 | — | 31 Mar 2025 |
Institutional Holders of Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) as of Q2 2025
As of 30 Jun 2025,
Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,685,530 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, FRANKLIN RESOURCES INC, ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, Nantahala Capital Management, LLC, BlackRock, Inc., INFINITUM ASSET MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Schonfeld Strategic Advisors LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
37
Q2 2025 holders
56
Holder diff
19
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.